| Reference |
|---|
Son B, Yoon H, Ryu J, Lee H, Joo J, Park H, et al. Enhanced efficiency of generating human-induced pluripotent stem cells using Lin28-30Kc19 fusion protein. Front Bioeng Biotechnol. 2022;10:911614 pubmed publisher |
von Joest M, Chen C, Douch xe9 T, Chantrel J, Chiche A, Gianetto Q, et al. Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming. Cell Rep. 2022;40:111074 pubmed publisher |
Borisova E, Nishimura K, An Y, Takami M, Li J, Song D, et al. Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency. iScience. 2022;25:103525 pubmed publisher |
Setthawong P, Phakdeedindan P, Techakumphu M, Tharasanit T. Molecular signature and colony morphology affect in vitro pluripotency of porcine induced pluripotent stem cells. Reprod Domest Anim. 2021;56:1104-1116 pubmed publisher |
Wang L, Zhao H, Wu J, Ren J, Luo H, Zuo X, et al. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual. Stem Cell Res. 2021;53:102336 pubmed publisher |
Sanchez Vazquez R, Martinez P, Blasco M. AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis. PLoS Genet. 2021;17:e1009410 pubmed publisher |
Sanzhez Mata A, Ferez Gomez A, González Muñoz E. Protocol to Reprogram Human Menstrual Blood-Derived Stromal Cells to Generate AOX15-iPSCs. STAR Protoc. 2020;1:100183 pubmed publisher |
Wei H, Beeson G, Ye Z, Zhang J, Yao H, Damon B, et al. Activation of Wnt/β-catenin signalling and HIF1α stabilisation alters pluripotency and differentiation/proliferation properties of human-induced pluripotent stem cells. Biol Cell. 2020;: pubmed publisher |
Kim K, Yoon J, Kim J, Röpke A, Shin B, Wook Han D, et al. Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy. Stem Cell Res. 2020;48:101993 pubmed publisher |
Kim K, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, et al. Reprogramming competence of OCT factors is determined by transactivation domains. Sci Adv. 2020;6: pubmed publisher |
Kim K, Yoon J, Shin B, Röpke A, Han D, Scholer H. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease. Stem Cell Res. 2020;46:101839 pubmed publisher |
Glaß H, Neumann P, Pal A, Reinhardt P, Storch A, Sterneckert J, et al. Combined Dendritic and Axonal Deterioration Are Responsible for Motoneuronopathy in Patient-Derived Neuronal Cell Models of Chorea-Acanthocytosis. Int J Mol Sci. 2020;21: pubmed publisher |
Uysal B, Löffler H, Rosa F, Lerche H, Schwarz N. Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation. Stem Cell Res. 2019;40:101543 pubmed publisher |
Dutton L, Dudhia J, Guest D, Connolly D. Inducing Pluripotency in the Domestic Cat (Felis catus). Stem Cells Dev. 2019;28:1299-1309 pubmed publisher |
Park J, Jun E, Son D, Hong W, Jang J, Yun W, et al. Overexpression of Nanog in amniotic fluid-derived mesenchymal stem cells accelerates dermal papilla cell activity and promotes hair follicle regeneration. Exp Mol Med. 2019;51:72 pubmed publisher |
Liu L, Li Y, Guo N, Li S, Ma X, Zhang Y, et al. Therapeutic Potential of Patient iPSC-Derived iMelanocytes in Autologous Transplantation. Cell Rep. 2019;27:455-466.e5 pubmed publisher |
Setthawong P, Phakdeedindan P, Tiptanavattana N, Rungarunlert S, Techakumphu M, Tharasanit T. Generation of porcine induced-pluripotent stem cells from Sertoli cells. Theriogenology. 2019;127:32-40 pubmed publisher |
Schwarz N, Uysal B, Rosa F, Löffler H, Mau Holzmann U, Liebau S, et al. Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation. Stem Cell Res. 2018;33:6-9 pubmed publisher |
Pane L, Fulcoli F, Cirino A, Altomonte A, Ferrentino R, Bilio M, et al. Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer. Dis Model Mech. 2018;11: pubmed publisher |
Phakdeedindan P, Setthawong P, Tiptanavattana N, Rungarunlert S, Ingrungruanglert P, Israsena N, et al. Rabbit induced pluripotent stem cells retain capability of in vitro cardiac differentiation. Exp Anim. 2019;68:35-47 pubmed publisher |
Sambathkumar R, Akkerman R, Dastidar S, Roelandt P, Kumar M, Bajaj M, et al. Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells. PLoS ONE. 2018;13:e0197046 pubmed publisher |
Baird A, Lindsay T, Everett A, Iyemere V, Paterson Y, McClellan A, et al. Osteoblast differentiation of equine induced pluripotent stem cells. Biol Open. 2018;7: pubmed publisher |
Thekkeparambil Chandrabose S, Sriram S, Subramanian S, Cheng S, Ong W, Rozen S, et al. Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming. Stem Cell Res Ther. 2018;9:68 pubmed publisher |
Salas S, Ng N, Gerami Naini B, Anchan R. Induced Pluripotent Stem Cells from Ovarian Tissue. Curr Protoc Hum Genet. 2017;95:21.10.1-21.10.22 pubmed publisher |
Chakritbudsabong W, Sariya L, Pamonsupornvichit S, Pronarkngver R, Chaiwattanarungruengpaisan S, Ferreira J, et al. Generation of a pig induced pluripotent stem cell (piPSC) line from embryonic fibroblasts by incorporating LIN28 to the four transcriptional factor-mediated reprogramming: VSMUi001-D. Stem Cell Res. 2017;24:21-24 pubmed publisher |
Bansho Y, Lee J, Nishida E, Nakajima Koyama M. Identification and characterization of secreted factors that are upregulated during somatic cell reprogramming. FEBS Lett. 2017;591:1584-1600 pubmed publisher |
Verusingam N, Yeap S, Ky H, Paterson I, Khoo S, Cheong S, et al. Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming. Peerj. 2017;5:e3174 pubmed publisher |
Zhang L, Jambusaria A, Hong Z, Marsboom G, Toth P, Herbert B, et al. SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34+ Progenitor Cells. Circulation. 2017;135:2505-2523 pubmed publisher |
Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed publisher |
Zhu Z, Li C, Zeng Y, Ding J, Qu Z, Gu J, et al. PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs. Cell Stem Cell. 2017;20:274-289.e7 pubmed publisher |
Rivera T, Haggblom C, Cosconati S, Karlseder J. A balance between elongation and trimming regulates telomere stability in stem cells. Nat Struct Mol Biol. 2017;24:30-39 pubmed publisher |
Zapata Linares N, Rodriguez S, Mazo M, Abizanda G, Andreu E, Barajas M, et al. Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue. Stem Cell Res. 2016;16:20-3 pubmed publisher |
Eid W, Abdel Rehim W. Vitamin C promotes pluripotency of human induced pluripotent stem cells via the histone demethylase JARID1A. Biol Chem. 2016;397:1205-1213 pubmed publisher |
Zukeran A, Takahashi A, Takaoka S, Mohamed H, Suzuki T, Ikematsu S, et al. The CCR4-NOT deadenylase activity contributes to generation of induced pluripotent stem cells. Biochem Biophys Res Commun. 2016;474:233-239 pubmed publisher |
Villa Diaz L, Kim J, Laperle A, Palecek S, Krebsbach P. Inhibition of Focal Adhesion Kinase Signaling by Integrin ?6?1 Supports Human Pluripotent Stem Cell Self-Renewal. Stem Cells. 2016;34:1753-64 pubmed publisher |
Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher |
Bhutani K, Nazor K, Williams R, Tran H, Dai H, Dzakula Z, et al. Whole-genome mutational burden analysis of three pluripotency induction methods. Nat Commun. 2016;7:10536 pubmed publisher |
Malan D, Zhang M, Stallmeyer B, Müller J, Fleischmann B, Schulze Bahr E, et al. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Res Cardiol. 2016;111:14 pubmed publisher |
Ryu J, Park H, Park J, Lee H, Rhee W, Park T. Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein. Appl Microbiol Biotechnol. 2016;100:3523-32 pubmed publisher |
Qian X, Kim J, Tong W, Villa Diaz L, Krebsbach P. DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover. Stem Cells. 2016;34:588-600 pubmed publisher |
Saito Y, Nakamura K, Yoshida M, Sugiyama H, Ohe T, Kurokawa J, et al. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker. PLoS ONE. 2015;10:e0138193 pubmed publisher |
Gallego Romero I, Pavlovic B, Hernando Herraez I, Zhou X, WARD M, Banovich N, et al. A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. elife. 2015;4:e07103 pubmed publisher |
Doerr J, Böckenhoff A, Ewald B, Ladewig J, Eckhardt M, Gieselmann V, et al. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy. Mol Ther. 2015;23:1519-31 pubmed publisher |
Fuerstenau Sharp M, Zimmermann M, Stark K, Jentsch N, Klingenstein M, Drzymalski M, et al. Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells. PLoS ONE. 2015;10:e0126596 pubmed publisher |
Chuang C, Huang M, Chen H, Tseng L, Yu C, Stone L, et al. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential. Stem Cell Res Ther. 2015;6:14 pubmed publisher |
Tatarishvili J, Oki K, Monni E, Koch P, Memanishvili T, Buga A, et al. Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. Restor Neurol Neurosci. 2014;32:547-58 pubmed publisher |
Hartfield E, Yamasaki Mann M, Ribeiro Fernandes H, Vowles J, James W, Cowley S, et al. Physiological characterisation of human iPS-derived dopaminergic neurons. PLoS ONE. 2014;9:e87388 pubmed publisher |
Srinivasakumar N, Zaboikin M, Tidball A, Aboud A, Neely M, Ess K, et al. Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation. Peerj. 2013;1:e224 pubmed publisher |
Goh P, Caxaria S, Casper C, Rosales C, Warner T, Coffey P, et al. A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS ONE. 2013;8:e81622 pubmed publisher |
Nagura S, Otaka S, Koike C, Okabe M, Yoshida T, Fathy M, et al. Effect of exogenous Oct4 overexpression on cardiomyocyte differentiation of human amniotic mesenchymal cells. Cell Reprogram. 2013;15:471-80 pubmed publisher |
Wezel F, Pearson J, Kirkwood L, Southgate J. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer. Am J Pathol. 2013;183:1128-1136 pubmed publisher |
Osteil P, Tapponnier Y, Markossian S, Godet M, Schmaltz Panneau B, Jouneau L, et al. Induced pluripotent stem cells derived from rabbits exhibit some characteristics of naïve pluripotency. Biol Open. 2013;2:613-28 pubmed publisher |
Reinhardt P, Glatza M, Hemmer K, Tsytsyura Y, Thiel C, Höing S, et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE. 2013;8:e59252 pubmed publisher |
Ruiz S, Gore A, Li Z, Panopoulos A, Montserrat N, Fung H, et al. Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming. Nat Commun. 2013;4:1382 pubmed publisher |
Chan Y, Goke J, Lu X, Venkatesan N, Feng B, Su I, et al. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming. Stem Cells. 2013;31:682-92 pubmed publisher |
Mahalingam D, Kong C, Lai J, Tay L, Yang H, Wang X. Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells. Sci Rep. 2012;2:592 pubmed publisher |
Frank S, Zhang M, Scholer H, Greber B. Small molecule-assisted, line-independent maintenance of human pluripotent stem cells in defined conditions. PLoS ONE. 2012;7:e41958 pubmed publisher |
Mak S, Huang Y, Iranmanesh S, Vangipuram M, Sundararajan R, Nguyen L, et al. Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int. 2012;2012:140427 pubmed publisher |
Sugii S, Kida Y, Berggren W, Evans R. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc. 2011;6:346-58 pubmed publisher |
Liu G, Barkho B, Ruiz S, Diep D, Qu J, Yang S, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature. 2011;472:221-5 pubmed publisher |
Ruiz S, Brennand K, Panopoulos A, Herrerias A, Gage F, Izpisua Belmonte J. High-efficient generation of induced pluripotent stem cells from human astrocytes. PLoS ONE. 2010;5:e15526 pubmed publisher |
Spence J, Mayhew C, Rankin S, Kuhar M, Vallance J, Tolle K, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470:105-9 pubmed publisher |
Kamata M, Liu S, Liang M, Nagaoka Y, Chen I. Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter. Hum Gene Ther. 2010;21:1555-67 pubmed publisher |
Germanguz I, Sedan O, Zeevi Levin N, Shtrichman R, Barak E, Ziskind A, et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med. 2011;15:38-51 pubmed publisher |
Hotta A, Cheung A, Farra N, Garcha K, Chang W, Pasceri P, et al. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat Protoc. 2009;4:1828-44 pubmed publisher |
Moretti A, Bellin M, Jung C, Thies T, Takashima Y, Bernshausen A, et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 2010;24:700-11 pubmed publisher |
Byrne J, Nguyen H, Reijo Pera R. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS ONE. 2009;4:e7118 pubmed publisher |
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72 pubmed |
